The Verdict From Mock Trial of Tech Titans
Last night was the 24th Annual Genesys Partners Venture Capital Dinner & Forum at the historic Union League Club in New York City. Nearly 100 investors, analysts, journalists, and key influencers attended. CEO James Kollegger kicked off the evening and introduced Dr. Michael R. Nelson. Mike advises governments on Internet technology issues for Cloudflare, a startup that has improved […]
AI and Congress
On April 10th and 11th, 2018, Facebook CEO Mark Zuckerberg was questioned for almost 10 hours by senators and representatives before joint Senate Judiciary and Commerce Committees regarding the company’s privacy policies and use of data collected on the company’s social media web site. The most used phrase in Mr. Zuckerberg’s responses was AI (artificial […]
Regenerative Medicine for Kidneys
I have written a number of articles here about regenerative medicine. The reason I think the topic is so important is 115,000 people are waiting for a lifesaving transplant. Another person is added to the waiting list every 10 minutes. Twenty-two people die each day because the organ they need is not donated in time. One organ, eye, and […]
Ridgefield Library: It’s All About Attitude with John Patrick
The Ridgefield Library is pleased to have author John Patrick back for his fourth visit. The lively talk, called It’s All About Attitude, will be at 7PM on Thursday, April 5. John believes many opportunities and problems have their roots in attitude. He also believes the solutions and ways forward are based on attitude. In his revealing talk, […]
Gene-editing Gets Major Funding
Last year, I wrote about a team of Chinese scientists having received ethical approval to perform a clinical trial of gene-editing. The goal was to test whether gene-editing may be a potential cure for cancer. The technology used for the trial is called CRISPR/Cas9, not exactly a household name. CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats. Cas9 stands for […]